Target intelligence / Profile preview

Omega-gliadin and gamma-gliadin

Molecular classification
Prolamin, Storage protein, Other
01

Overview

Omega-gliadin and gamma-gliadin are alcohol-soluble prolamin proteins found in wheat that serve as essential nutrient storage for the plant embryo (UniProt P02865, P08453). In humans, these proteins are notoriously difficult to digest due to their high proline and glutamine content, which resists standard gastrointestinal proteolysis (Scherf et al., 2016). The resulting undigested peptides can cross the intestinal epithelial barrier, where they are deamidated by tissue transglutaminase 2, significantly increasing their immunogenicity in individuals carrying HLA-DQ2 or HLA-DQ8 alleles. This process triggers the inflammatory T-cell response characteristic of Celiac Disease and is also linked to wheat-dependent exercise-induced anaphylaxis, particularly involving the omega-5 gliadin fraction (Morita et al., 2003). Therapeutic strategies targeting these proteins include the development of oral proteases, such as Latiglutenase and TAK-062, designed to break down immunogenic epitopes within the stomach (Lahdeaho et al., 2014). Additionally, sequestering agents like BL-7010 are being explored to bind these proteins and prevent their interaction with the immune system. Peptide-based vaccines like Nexvax2 have also aimed to induce immune tolerance by exposing the immune system to specific gliadin epitopes (Tye-Din et al., 2010). These interventions represent a shift toward non-dietary management of gluten-related disorders by directly neutralizing the pathogenic trigger.

Other names
Omega-gliadinGamma-gliadinProlaminWheat gluten proteinGluten
02

Mechanism of action

Proteolytic degradation of immunogenic peptides, sequestration of proteins in the gut lumen, and induction of immune tolerance through peptide-based immunotherapy.

03

Biological functions

Nutrient storageImmune response inductionOther
04

Disease associations

Celiac diseaseWheat-dependent exercise-induced anaphylaxis (WDEIA)Wheat allergyDermatitis herpetiformisOther
05

Safety considerations

Incomplete degradation of toxic epitopesPotential for allergic reactions to therapeutic enzymesEfficacy dependence on gastric pH and residence timeTherapeutic challenges
06

Interacting drugs

Latiglutenase

4 more in the full profile.

07

Biomarkers

Anti-deamidated gliadin peptide (DGP) antibodiesAnti-gliadin antibodies (AGA)HLA-DQ2HLA-DQ8Serum omega-5 gliadin-specific IgE

Beyond the preview

Go deeper on Omega-gliadin and gamma-gliadin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omega-gliadin and gamma-gliadin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call